Roy Golan work email
- Valid
- Valid
Roy Golan personal email
A registered CPA with a broad experience in aspects of Nasdaq, IPOs & M&As .Managed financial roles in small and medium sized Pharmaceutical, Biotech, High-Tech and Medical Device companies, both private and public. Until June 2024, served as the Chief Financial Officer of Ayala Pharmaceuticals Inc. (OTC: ADXS) and as an Executive VP and CFO of BioSight Ltd. Led the merger between Biosight and Ayala Pharmaceuticals Inc. and played a major role in the Asset deal between Ayala Pharmaceuticals Inc. and Immunome (Nasdaq: IMNM).Previously served as President & CFO of Exalenz Ltd., a diagnostics company traded on TASE, later acquired by Meridian Bioscience, Inc. (VIVO). Previous to that, served as NDRM's CFO, had a pivotal role in their successful IPO, two Follow-On Offerings on Nasdaq and NDRM's acquisition by Mitsubishi Tanabe Pharmaceutical Corporation for a total of US$1.1 billion.
-
Chief Financial OfficerLivekidney.BioIsrael
-
Financial AdvisorBiotech/Medtech/Hightech Companies Jul 2024 - Present
-
Board MemberNeurosense Therapeutics Jul 2024 - PresentCambridge, Massachusetts, Us -
Chief Financial OfficerAyala Pharmaceuticals Oct 2023 - Jun 2024Ayala is a clinical-stage oncology company founded in November 2017 after acquiring an exclusive, worldwide license to our product candidates AL101 and AL102 from Bristol-Myers Squibb (BMS). On October 2023, Biosight Ltd. merged with Ayala Pharmaceuticals Inc. Led the merger between Biosight and Ayala Pharmaceuticals Inc. and played a major role in the Asset deal between Ayala Pharmaceuticals Inc. and Immunome (Nasdaq: IMNM) that closed in March 2024
-
Executive Vice President & CfoBiosight Ltd. Mar 2019 - Jun 2024Lod, -- Select One --, IlBiosight is a private Phase 2 clinical stage biotech company, developing innovative therapeutics for hematological malignancies and disorders. Biosight’s lead product, BST-236 (INN aspacytarabine), is an innovative proprietary anti-metabolite designed to enable high-dose chemotherapy with reduced systemic toxicity. -
President & Chief Financial OfficerExalenz Bioscience Ltd.; Acquired By Meridian Bioscience, Inc. (Vivo) May 2018 - Feb 2019Modiin, Israel, IlExalenz Bioscience (TASE: EXEN) is a global, commercial-stage diagnostics company using its BreathID® technology platform to improve patient care by providing advanced, innovative breath-based tests in the fields of gastroenterology and hepatology.The company is traded on the Tel-Aviv Stock Exchange. -
Chief Financial OfficerNeuroderm; (Acquired By Mitsubishi Tanabe) Aug 2015 - Apr 2018Rehovot, IlNeuroderm (NASDAQ: NDRM) is a clinical-stage pharmaceutical company developing drugs for central nervous system (CNS) diseases. As NDRM's CFO, had a pivotal role in our successful IPO, two Follow-On Offerings on Nasdaq (raising over $200M) and NDRM's recent acquisition by Mitsubishi Tanabe Pharmaceutical Corporation for a total of US$1.1 billion . -
Vice President FinanceNeuroderm; (Acquired By Mitsubishi Tanabe) Jan 2014 - Jul 2015Rehovot, Il
-
Board Member At Neuroderm Inc.Neuroderm Inc. Dec 2015 - Oct 2017
-
CfoKcs - Knowledge Control Systems; Acquired By Malam-Team May 2008 - Jun 2012Tel Aviv, IlSold in June 2012 to Malam Team -
Vp FinanceGi View Sep 2005 - Apr 2008Managed the Finance, Accounting, Legal,HR & Administrative departments.
-
Corporate ControllerOn Track Innovations, Ltd (Nasdaq: Otiv) Aug 2002 - Aug 2005• Pivotal role in all corporate financial matters.• Pivotal role in filing company on NASDAQ.• Lead role in implementing Sarbanes-Oxley, while serving as “SOX Champion”.
-
Senior ConsultantPricewaterhousecoopers (Pwc) Aug 1999 - Aug 2002GbSenior Consultant.
Roy Golan Skills
Roy Golan Education Details
-
Bar-Ilan UniversityLaw -
The College Of Management Academic StudiesBusiness And Accounting
-
Kugel High School
Frequently Asked Questions about Roy Golan
What company does Roy Golan work for?
Roy Golan works for Livekidney.bio
What is Roy Golan's role at the current company?
Roy Golan's current role is Chief Financial Officer.
What is Roy Golan's email address?
Roy Golan's email address is ro****@****erm.com
What schools did Roy Golan attend?
Roy Golan attended Bar-Ilan University, The College Of Management Academic Studies, Kugel High School.
What skills is Roy Golan known for?
Roy Golan has skills like Managerial Finance, Due Diligence, Finance, Accounting, Start Ups, Management, Corporate Finance, Mergers And Acquisitions, Financial Analysis, Auditing, Venture Capital, Sarbanes Oxley Act.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial